🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Humbled to be featured in the March/April edition of Prostatepedia NASPCC. I had the opportunity to discuss the impact of the PSMA PET scan on clinical decision-making, current clinical trials, biomarkers, and targeted therapies. online.flippingbook.com/view/670383721/

Stoked for our ASCO poster showing NK cell infiltration and survival benefit across numerous solid tumors. NK cells are coming for you prostate cancer!

Dr. Pedro C Barata, MD MSc FACP discusses the first in human Ph1 trial with CAR T-cell (anti-PSCA) therapy in mCRPC presented by Dr. Tanya Dorff. Unfortunately no objective responses seen. Other trials are ongoing evaluating other targets, and this strategy warrants further investigation. #ASCO23

Congrats Ali Arafa for delivering your first Oral ASCO Abstract. Your impactful study shows that germline mutations clearly influence somatic mutation landscapes in BRCA-associated cancers. ascopubs.org/doi/abs/10.120…

Vote for our team building picture! #PCFRetreat23

Further evidence that NK cells infiltrate immunologically "cold" prostate cancer tumors! rdcu.be/dzQg7 This is just the tip of the iceberg from this dataset. Thank you to PCF Science Masonic Cancer Center, University of Minnesota for funding and mentorship! Can't wait for our first PCa NK trial!

I am very excited to share that my recent review paper "Therapeutic approaches to enhance natural killer cell cytotoxicity," has been published! Take a look here: doi.org/10.3389/fimmu.…